A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Saved in:
| Title: | A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials. |
|---|---|
| Authors: | Fertitta L; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France.; INSERM U955 , 94010, Créteil, France., Bergqvist C; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France., Sarin KY; Department of Dermatology, Stanford Medicine, Stanford University, Redwood City, CA, USA., Plotkin SR; Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Moertel C; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA., Petersen AK; Department of Rehabilitation and Development, Randall Children's Hospital at Legacy Emanuel Medical Center, Portland, OR, 97227, USA., Cannon A; School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.; InformedDNA, Inc., St Petersburg, FL, USA., Berman Y; Clinical Genetics, Royal North Shore Hospital, St Leonards, NSW, Australia and University of Sydney, Sydney, Australia., Pichard DC; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases.; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute; National Institutes of Health, Bethesda, MD, USA., Röhl C; NF Patients United - Global Network of NF Support Groups, Vienna, Austria., Lessing A; Neurofibromatosis Northeast, Burlington, MA, USA., Brizion B; Centre de documentation de l'AP-HP, AP-HP, Paris, France., Peiffer B; Department of Dermatology., Ravaud P; Center for Clinical Epidemiology, Hôtel-Dieu Hospital (AP-HP), Paris, France.; Université de Paris, CRESS, INSERM, INRA , F-75004 Paris, France., Tran VT; Center for Clinical Epidemiology, Hôtel-Dieu Hospital (AP-HP), Paris, France.; Université de Paris, CRESS, INSERM, INRA , F-75004 Paris, France., Armand ML; Department of Dermatology., Moryousef S; Department of Dermatology., Ferkal S; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France., Jannic A; Department of Dermatology., Ezzedine K; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France.; Université Paris-Est Créteil (UPEC), 94010 Créteil, France., Wolkenstein P; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France.; INSERM U955, 94010, Créteil, France.; Université Paris-Est Créteil (UPEC), 94010 Créteil, France. |
| Corporate Authors: | Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) international collaboration |
| Source: | The British journal of dermatology [Br J Dermatol] 2024 Jan 23; Vol. 190 (2), pp. 216-225. |
| Publication Type: | Systematic Review; Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2133 |
|---|---|
| DOI: | 10.1093/bjd/ljad397 |
